Philip T. Ninan, MD
Article
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
February 5, 2015
Here, review results from a post hoc analysis that evaluated the tolerability of long-term desvenlafaxine for major depressive disorder at discontinuation using a taper regimen compared with abrupt discontinuation.Â
Article
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study
February 24, 2011
Read this article to examine results from a randomized, open-label, multicenter study that compared treatment outcomes with the serotonin-norepinephrine reuptake inhibitor venlafaxine extended release with selective serotonin reuptake inhibitors...
Article
Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women
February 18, 2010
In this review article, examine the risk of depression onset in perimenopausal and postmenopausal women and find out how to screen for and manage depression in your perimenopausal and...
